MEDICAL MANAGEMENT SYSTEMS INC
NT 10-K, 1999-04-01
BLANK CHECKS
Previous: WELLS REAL ESTATE FUND II-OW, NT 10-K, 1999-04-01
Next: NEXTEL COMMUNICATIONS INC, 8-K, 1999-04-01



<PAGE> 1
                          UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.   20549

                           FORM 12b-25
                   NOTIFICATION OF LATE FILING

[ x ] Form 10-K  [ ] Form 20-F  [ ] Form 11-K  [   ] Form 10-Q 

For the period ended December 31, 1998. 

     [ ] Transition Report on Form 10-K.
     [ ] Transition Report on Form 20-F.
     [ ] Transition Report on Form 11-K.
     [ ] Transition Report on Form 10-Q.
     For the Transition Period Ended:

If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:

PART I - REGISTRANT INFORMATION

                 MEDICAL MANAGEMENT SYSTEMS, INC.
                     Full Name of Registrant

                        File No.  0-29462   

                      5459 South Iris Street
                   Littleton, Colorado   80123 
_____________________________________________________________
      Address of principal executive office, including zip.

PART II - RULES 12B-25 and (c)

If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25, the following should be completed.

            (a)  The reasons described in reasonable detail in
                 Part III of this form could not be eliminated
                 without unreasonable effort or expense;
[ X ]       (b)  The subject annual report, semi-annual
                 report, transition report of Form 10-K, Form
                 20-F, 11K or Form N-SAR, or portion thereof,
                 will be filed on or before the fifteenth
                 calendar day following the prescribed due
                 date; or the subject quarterly report of
                 transition report on Form 10-Q, or portion
                 thereof will be filed on or before the fifth
                 calendar day following the prescribed due
                 date; and





<PAGE> 2
               (c)  The accountant's statement or other exhibit
                    required by Rule 12b-25(c) has been attached
                    if applicable.

PART III - NARRATIVE

The Registrant is unable to complete the financial statements
within the prescribed period.

PART IV - OTHER INFORMATION

1.   Name and telephone number of person to contact in regard to
     this notification.

     Philip J.  Davis, President
     Medical Management Systems, Inc.
     5459 South Iris Street
     Littleton, Colorado   80123
     (303) 932-9998
     
2.   Have all other periodic reports required under Section 13 or
     15(d) of the Securities Exchange Act of 1934 or Section 30 of
     the Investment Company Act of 1940 during the preceding 12
     months (or for such shorter) period that the registrant was
     required to file such reports) been filed?  If answer is no,
     identify reports.

                    Yes x               No 

3.   Is its anticipated that any significant change in results of
     operations from the corresponding period for the last fiscal
     year will be reflected by the earnings statements to be
     included in the subject report or portion thereof?

                    Yes                 No x 

     If so, attach an explanation of the anticipated change, both
     narratively and quantitatively, and, if appropriate, state the
     reasons why a reasonable estimate of the results cannot be
     made.

MEDICAL MANAGEMENT SYSTEMS, INC. has caused this notification to
signed on its behalf by the undersigned hereunto duly authorized,
on this 1st day of April, 1999.

                              MEDICAL MANAGEMENT SYSTEMS, INC. 


                              BY: /S/ Philip J. Davis
                                  Philip J.  Davis
                                  Title: President 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission